Experience of contamination during autologous cell manufacturing in cell processing facility under the Japanese Medical Practitioners Act and the Medical Care Act

Cell therapy and regenerative medicine technologies require strict cell manufacturing procedures to be defined and addressed. Maintenance of the aseptic environment is critical to preclude extrinsic contamination risks, similar to conventional pharmaceutical manufacturing. However, intrinsic contami...

Descripción completa

Detalles Bibliográficos
Autores principales: Mizutani, Manabu, Samejima, Hazuki, Terunuma, Hiroshi, Kino-oka, Masahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society for Regenerative Medicine 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581811/
https://www.ncbi.nlm.nih.gov/pubmed/31245497
http://dx.doi.org/10.1016/j.reth.2016.06.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581811/
https://www.ncbi.nlm.nih.gov/pubmed/31245497
http://dx.doi.org/10.1016/j.reth.2016.06.004

Ejemplares similares